Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Nasdaq, Inc. (NDAQ) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Financial Data & Stock Exchanges
$89.41
-1.32 (-1.45%)Did NDAQ Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Nasdaq is one of their latest high-conviction picks.
Based on our analysis of 27 Wall Street analysts, NDAQ has a bullish consensus with a median price target of $84.00 (ranging from $68.00 to $101.00). The overall analyst rating is Buy (7.9/10). Currently trading at $89.41, the median forecast implies a -6.1% downside. This outlook is supported by 13 Buy, 5 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Benjamin Budish at Barclays, projecting a 13.0% upside. Conversely, the most conservative target is provided by Owen Lau at Oppenheimer, suggesting a 23.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NDAQ.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jul 10, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $101.00 |
Jul 10, 2025 | UBS | Alex Kramm | Neutral | Maintains | $95.00 |
Jul 9, 2025 | Raymond James | Patrick O'Shaughnessy | Outperform | Maintains | $96.00 |
Jul 2, 2025 | Goldman Sachs | Alexander Blostein | Buy | Maintains | $97.00 |
Jun 17, 2025 | Oppenheimer | Owen Lau | Outperform | Maintains | $96.00 |
Apr 28, 2025 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $75.00 |
Apr 25, 2025 | UBS | Alex Kramm | Neutral | Maintains | $82.00 |
Apr 25, 2025 | Keefe, Bruyette & Woods | Kyle Voigt | Outperform | Maintains | $88.00 |
Apr 25, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $84.00 |
Apr 14, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $86.00 |
Apr 11, 2025 | Oppenheimer | Owen Lau | Outperform | Maintains | $85.00 |
Apr 10, 2025 | RBC Capital | Ashish Sabadra | Outperform | Reiterates | $95.00 |
Apr 8, 2025 | Citigroup | Christopher Allen | Neutral | Maintains | $75.00 |
Apr 8, 2025 | Piper Sandler | Richard Repetto | Overweight | Maintains | $83.00 |
Apr 8, 2025 | Morgan Stanley | Equal-Weight | Downgrade | $0.00 | |
Apr 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $87.00 |
Apr 2, 2025 | B of A Securities | Craig Siegenthaler | Buy | Maintains | $105.00 |
Jan 30, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $95.00 |
Jan 30, 2025 | JP Morgan | Michael Cho | Overweight | Maintains | $95.00 |
Jan 30, 2025 | UBS | Alex Kramm | Neutral | Maintains | $89.00 |
The following stocks are similar to Nasdaq based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nasdaq, Inc. has a market capitalization of $51.33B with a P/E ratio of 40.5x. The company generates $7.82B in trailing twelve-month revenue with a 16.4% profit margin.
Revenue growth is +24.9% quarter-over-quarter, while maintaining an operating margin of +27.4% and return on equity of +11.4%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Operates a leading global electronic securities exchange.
The company generates revenue primarily through transaction fees from securities trading, listings, and market data services. Additionally, it offers financial technology solutions, providing analytics and investor relations services to institutional and corporate clients, which further diversifies its income streams.
Founded in 1971, the company plays a crucial role in capital markets, especially for technology and innovation-driven sectors. It is recognized as a marketplace for major tech companies and continuously advances its operations to maintain a competitive edge in the financial services industry.
Financial Services
Financial Data & Stock Exchanges
9,377
Ms. Adena T. Friedman
United States
2002
Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
OTC Markets Group (OTCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Nasdaq announced the delisting of NKGen Biotech, Inc.'s common stock and warrants, which have been suspended from trading since March 5, 2025.
Delisting of NKGen Biotech indicates financial instability, reducing investor confidence and potentially impacting related biotech stocks and overall market sentiment.
Nasdaq reported June 2025 monthly volumes and Q2 2025 metrics, including estimated revenue capture, listings, and index statistics, available on its Investor Relations website.
Nasdaq's reported volumes and revenue capture provide insights into market activity and performance, influencing investor sentiment and stock valuations for the exchange and listed companies.
As of June 30, 2025, short interest in 3,257 Nasdaq securities rose to 14.14 billion shares, up from 13.69 billion on June 13. This equates to 2.59 days of short interest, an increase from 2.32 days.
Rising short interest indicates increased bearish sentiment in the market, suggesting potential volatility and trading opportunities in Nasdaq securities.
Nasdaq is projected to grow due to rising on-trading revenue, strong organic growth, investments in proprietary data, and a solid capital position.
Rising on-trading revenue and strong organic growth signal Nasdaq's financial health, potentially boosting investor confidence and stock value. Solid capital position enhances growth prospects.
A buy rating on Nasdaq is reaffirmed, citing strong profit margins, growth potential, and favorable market conditions. The company also offers proven dividend growth and robust operating cash flow.
The reaffirmed buy rating on Nasdaq suggests continued growth potential, driven by strong profit margins and trading volume, appealing to both growth and dividend-focused investors.
Nasdaq shows strong momentum; however, the IPO market is weak, and valuations exceed 25x forward earnings. Analysts suggest holding unless shares drop to $84-$85 support.
Strong Nasdaq momentum contrasts with a weak IPO market and high valuations, indicating potential risk. Earnings growth relies on cost controls, not revenue, suggesting caution ahead.
Based on our analysis of 27 Wall Street analysts, Nasdaq, Inc. (NDAQ) has a median price target of $84.00. The highest price target is $101.00 and the lowest is $68.00.
According to current analyst ratings, NDAQ has 13 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $89.41. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict NDAQ stock could reach $84.00 in the next 12 months. This represents a -6.1% decrease from the current price of $89.41. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue primarily through transaction fees from securities trading, listings, and market data services. Additionally, it offers financial technology solutions, providing analytics and investor relations services to institutional and corporate clients, which further diversifies its income streams.
The highest price target for NDAQ is $101.00 from Benjamin Budish at Barclays, which represents a 13.0% increase from the current price of $89.41.
The lowest price target for NDAQ is $68.00 from Owen Lau at Oppenheimer, which represents a -23.9% decrease from the current price of $89.41.
The overall analyst consensus for NDAQ is bullish. Out of 27 Wall Street analysts, 13 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $84.00.
Stock price projections, including those for Nasdaq, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.